Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

NCT02244216 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02244216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02244216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmarketing Surveillance Study (as Per § 67 (6) AMG [German Drug Law]) of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 30, 2000
Completion date
Not reported
Enrollment
2,914 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive